Accumulating evidence suggests that NAT10-mediated ac4C modification is involved in the pathogenesis of various diseases, such as osteogenesis [38], myocardial infarction [39], tumor progression [40, 41], cardiac remodeling [42], and inflammation [43]. The gene discussed is NAT10; the disease is myocardial infarction.